MEX3C shows promise as novel therapeutic target against LUAD
March 4, 2024
Scientists from First Affiliated Hospital Bengbu Medical College and affiliated organizations have studied the role of the RNA-binding ubiquitin ligase MEX3C in lung adenocarcinoma (LUAD).